Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
OTC Markets OTCPK - Delayed Quote USD

Assura Plc (ARSSF)

Compare
0.5400
+0.0400
+(8.00%)
As of March 7 at 3:00:00 PM EST. Market Open.
Loading Chart for ARSSF
  • Previous Close 0.5000
  • Open 0.5000
  • Bid 0.5616 x 308300
  • Ask 0.6400 x 306000
  • Day's Range 0.5000 - 0.5000
  • 52 Week Range 0.4320 - 0.5800
  • Volume 4,000
  • Avg. Volume 164
  • Market Cap (intraday) 1.755B
  • Beta (5Y Monthly) 0.36
  • PE Ratio (TTM) 18.00
  • EPS (TTM) 0.0300
  • Earnings Date May 19, 2025 - May 23, 2025
  • Forward Dividend & Yield 0.04 (8.02%)
  • Ex-Dividend Date Mar 6, 2025
  • 1y Target Est --

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion. At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

www.assuraplc.com

84

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ARSSF

View More

Performance Overview: ARSSF

Trailing total returns as of 3/10/2025, which may include dividends or other distributions. Benchmark is FTSE 100 .

YTD Return

ARSSF
9.98%
FTSE 100
5.43%

1-Year Return

ARSSF
9.66%
FTSE 100
12.50%

3-Year Return

ARSSF
19.02%
FTSE 100
21.38%

5-Year Return

ARSSF
49.44%
FTSE 100
44.57%

Compare To: ARSSF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ARSSF

View More

Valuation Measures

Annual
As of 3/7/2025
  • Market Cap

    1.71B

  • Enterprise Value

    3.73B

  • Trailing P/E

    19.96

  • Forward P/E

    11.32

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.70

  • Price/Book (mrq)

    0.85

  • Enterprise Value/Revenue

    17.63

  • Enterprise Value/EBITDA

    29.85

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    40.21%

  • Return on Assets (ttm)

    2.74%

  • Return on Equity (ttm)

    4.23%

  • Revenue (ttm)

    164.4M

  • Net Income Avi to Common (ttm)

    66.1M

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.2M

  • Total Debt/Equity (mrq)

    100.10%

  • Levered Free Cash Flow (ttm)

    15.39M

Research Analysis: ARSSF

View More

Company Insights: ARSSF

Research Reports: ARSSF

View More

People Also Watch